Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

Tendon stem/progenitor cells regulate inflammation in tendon healing via JNK and STAT3 signaling

Tarafder S., Chen E., Jun Y., Kao K., Sim KH., Back J.

Animal Study on Tendon Injury, Chronic Inflammation, published in FASEB J (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
FASEB J (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28533328
PMCID
PMC5572690
DOI
10.1096/fj.201700071r
Citations
64

Abstract (original English)

Tendon stem/progenitor cells (TSCs) have been found in different anatomic locations and showed a promising regenerative potential. We identified a role of TSCs in the regulation of inflammation during healing of acute tendon injuries. Delivery of connective tissue growth factor (CTGF) into full-transected rat patellar tendons significantly increased the number of CD146 + TSCs, leading to enhanced healing. In parallel, CTGF delivery significantly reduced the number of iNOS + M1 macrophages and increased the expression of anti-inflammatory IL-10 at 2 d after surgery, with over 85% CD146 + TSCs expressing IL-10. By 1 wk, the elevated IL-10 expression remained, and IL-6 expression was significantly attenuated in CTGF-delivered tendon healing. Matrix metalloproteinase (MMP)-3 expression in CTGF-delivered tendon was organized along with the reorienting collagen fibers by 1 wk after surgery, in comparison with the control group showing the abundant MMP-3 expression localized at healing junction. Tissue inhibitor of metalloprotease (TIMP)-3 was expressed in CD146 + TSCs at 1 wk with CTGF, in contrast to control with no TIMP-3 expression. In vitro , IL-10 expression was detected only when tendon cells were stimulated with IL-1β, and CTGF and significantly higher in CD146 + TSCs than CD146 - tendon cells. Similarly, TIMP-3 expression was detected only when treated with CTGF or CTGF and I

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
TendonsStem CellsAnimalsRatsRats, Sprague-DawleyTendon InjuriesInflammationMAP Kinase Kinase 4Tissue Inhibitor of Metalloproteinase-3Cytokines

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research